The virus has been designed specifically to kill cancer and works by enhancing the body's immune response against cancer cells.

Even when detected early, patients suffering from pervasive triple negative breast cancer have only a one-in-ten chance of a cure.

Too many women are getting unnecessary mastectomies and other invasive procedures due to a knowledge gap about differences in cancer genes.

A repair robot that takes inspiration from the bendiness and sensing ability of snakes is now being exploited for use in human surgery.

The most common head and neck cancer—oral squamous cell carcinoma—often starts off, as many other cancers do, quite innocently.

Researchers are buzzing over a new study that says venom from bees can kill cancer cells within an hour, without causing harm to other cells

Viral mimicry, tricks the body into thinking that it has a viral infection, stimulating immune responses that can help the body fight cancer

Patients suffering from pervasive triple negative breast cancer have a one-in-ten chance of a cure.

Last week, 26-year-old Caleb Lee rang a bell that signaled his final cancer treatment, and he pulled the string right off.

Rice University bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days.

The cancer community is buzzing over a new study that says venom from bees can kill cancer cells.

A 10-year-old girl is dedicating her time to crafting "chemo comfort bags" for hospital patients after seeing her grandfather battle cancer.

Scientists have developed mathematical models that act as patient ‘surrogates’ for evaluating potential prostate cancer treatments.

A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed.

The cancer community is buzzing over a new study that says venom from bees can kill cancer cells.

A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed.

The test is inexpensive and uses a test strip and a small cube-shaped 1.6-inch reader to quantify a marker of prostate cancer.

A blood test, combined with a risk model based on an individual’s history, more accurately determines who will benefit from screenings.

A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state.

Researchers suggest that a 2.5-year regimen involving ibrutinib and chemoimmunotherapy can provide deep, and lasting remissions.